首页> 外国专利> Remedy for CAG repeat expansion diseases

Remedy for CAG repeat expansion diseases

机译:CAG重复性扩张疾病的治疗

摘要

To elucidate the molecular mechanisms of gain of toxic function of expanded polyglutamine stretches in CAG repeat expansion diseases, the inventors established an expression system of full-length and truncated cDNAs for dentatorubral-pallidoluysian atrophy (DRPLA) and found that truncated DRPLA proteins containing the expanded polyglutamine stretch, but not the full-length protein, form peri- and intra-nuclear aggregates consisting of filaments and concomitant apoptosis. The apoptotic cell death was partially suppressed by transglutaminase inhibitors, cystamine and monodansyl cadaverine, raising the possibility of involvement of transglutaminase reaction. The results may provide a potential basis for the development of therapeutic measures for CAG repeat expansion diseases.
机译:为了阐明在CAG重复扩增疾病中获得扩增的聚谷氨酰胺片段的毒性功能的分子机制,发明人建立了全长和被截断的cDNA,用于牙本质-古卢氏肌萎缩症(DRPLA)的表达系统,并且发现了包含扩增的截短的DRPLA蛋白多聚谷氨酰胺伸展,但不是全长蛋白,形成由细丝和伴随的细胞凋亡组成的核周和核内聚集体。转谷氨酰胺酶抑制剂,胱胺和单丹酰尸胺可部分抑制凋亡细胞的死亡,从而增加了转谷氨酰胺酶反应参与的可能性。该结果可为开发CAG重复扩增疾病的治疗措施提供潜在的基础。

著录项

  • 公开/公告号US6355690B1

    专利类型

  • 公开/公告日2002-03-12

    原文格式PDF

  • 申请/专利权人 NIIGATA UNIVERSITY;

    申请/专利号US19990236002

  • 发明设计人 SHOJI TSUJI;

    申请日1999-01-22

  • 分类号A61K310/95;

  • 国家 US

  • 入库时间 2022-08-22 00:49:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号